[1] HOLVOET T, RAEVENS S, VANDEWYNCKEL Y P, et al. Systematic review of guidelines for management of intermediate hepatocellular carcinoma using the appraisal of guidelines research and evaluation Ⅱ instrument[J]. Dig Liver Dis, 2015, 47(10): 877-883. DOI: 10.1016/j.dld.2015.07.005. [2] GILLES H, GARBUTT T, LANDRUM J. Hepatocellular carcinoma[J]. Crit Care Nurs Clin N Am, 2022, 34(3): 289-301. DOI: 10.1016/j.cnc.2022.04.004. [3] LUO P, WU S Y, YU Y L, et al. Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier sage[J]. Pathol Oncol Res, 2020, 26(2): 599-603. DOI: 10.1007/s12253-019-00585-5. [4] WANG W Y, WEI C. Advances in the early diagnosis of hepatocellular carcinoma[J]. Genes Dis, 2020, 7(3): 308-319. DOI: 10.1016/j.gendis.2020.01.014. [5] LEE J S, LIM T S, LEE H W, et al. Suboptimal performance of hepatocellular carcinoma prediction models in patients with hepatitis B virus-related cirrhosis[J]. Diagnostics, 2022, 13(1): 3. DOI: 10.3390/diagnostics13010003. [6] MARENGO A, ROSSO C, BUGIANESI E. Liver cancer: connections with obesity, fatty liver, and cirrhosis[J]. Annu Rev Med, 2016, 67: 103-117. DOI: 10.1146/annurev-med-090514-013832. [7] GONG C W, AI J Y, FAN Y, et al. NCAPG promotes the proliferation of hepatocellular carcinoma through PI3K/AKT signaling[J]. Onco Targets Ther, 2019, 12: 8537-8552.. DOI: 10.2147/OTT.S217916 [8] 思兰兰. INTS10蛋白抑制乙型肝炎病毒复制的分子机制的初步研究[D].南宁:广西医科大学, 2015. DOI: 10.7666/d.Y2876795 [9] LUI K Y, ZHAO H, QIU C H, et al. Integrator complex subunit 6(INTS6)inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker[J]. BMC Cancer, 2017, 17(1): 644. DOI: 10.1186/s12885-017-3628-3. [10] LI Z B, ZHU P W, WANG M L, et al. Correlation between oncogene integrator complex subunit 7 and a poor prognosis in lung adenocarcinoma[J]. J Thorac Dis, 2022, 14(12): 4815-4827. DOI: 10.21037/jtd-22-1533. [11] ELENA S, MOHINI L, ANNAMIL A T, et al. NACK and INTEGRATOR act coordinately to activate Notch-mediated transcription in tumorigenesis[J]. Cell Commun Signal, 2021, 19(1): 96. DOI:10.1186/s12964-021-00776-1. [12] INAGAKI Y, YASUI K, ENDO M, et al. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma[J]. Cancer Genet Cytogenet, 2008, 180(1): 30-36. DOI: 10.1016/j.cancergencyto.2007.09.013. [13] JUNG H M, CHOI S J, KIM J K. Expression profiles of SV40-immortalization-associated genes upregulated in various human cancers[J]. J Cell Biochem, 2009, 106(4): 703-713. DOI: 10.1002/jcb.22063. [14] SIMPSON H M, KHAN R Z, SONG C, et al. Concurrent Mutations in ATM and genes associated with common γ chain signaling in peripheral T cell lymphoma[J]. PLoS One, 2015, 10(11): e0141906. DOI: 10.1371/journal.pone.0141906. [15] LI Y F, SI L L, ZHAI Y, et al. Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese[J].Nat Commun, 2016, 7: 11664. DOI: 10.1038/ncomms11664. [16] 张静,程敏,金倩,等.多聚嘧啶区结合蛋白1通过调控基因的可变剪接促进胆管癌细胞的生长、迁移及侵袭能力[J].中国生物化学与分子生物学报, 2022, 38(7): 899-910. DOI:10.13865/j.cnki.cjbmb.2022.06.1058. [17] 霍励耘,魏英城,谭文亮,等.SMC基因家族在肝癌中的表达及其预测肝癌预后的临床意义[J].岭南现代临床外科, 2021, 21(1): 24-28. DOI: 10.3969/j.issn.1009-976X.2021.01.005. [18] 马孟杰,彭小忠,舒鹏程.COMPASS核心成员Ash2l通过调控细胞周期影响神经祖细胞增殖[J].中国生物化学与分子生物学报, 2022, 38(6): 742-748. DOI: 10.13865/j.cnki.cjbmb.2022.05.1090. [19] KREIS N N, LOUWEN F, YUAN J P. The multifaceted p21(Cip1/Waf1/CDKN1A)in cell differentiation, migration and cancer therapy[J]. Cancers, 2019, 11(9): 1220. DOI: 10.3390/cancers11091220. [20] CHANDRASEKARAN A P, SURESH B, SARODAYA N, et al. Ubiquitin specific protease 29 functions as an oncogene promoting tumorigenesis in colorectal carcinoma[J]. Cancers, 2021, 13(11): 2706. DOI: 10.3390/cancers13112706. [21] SHEN T, HUANG S L. The role of Cdc25A in the regulation of cell proliferation and apoptosis[J]. Anticancer Agents Med Chem, 2012, 12(6): 631-639. DOI: 10.2174/187152012800617678. [22] WANG C, ZENG J, LI L J, et al. Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells[J]. Cell Death Dis, 2021, 12(11): 1055. DOI: 10.1038/s41419-021-04342-y. [23] KAYA Z, KARAN B M, ALMAL1 N. CDKN1A(p21 gene)polymorphisms correlates with age in esophageal cancer[J]. Mol Biol Rep, 2022, 49(1): 249-258. DOI: 10.1007/s11033-021-06865-1. [24] HAN J, ZHANG Z X. Screening of pyroptosis-related genes influencing the therapeutic effect of dehydroabietic acid in liver cancer and construction of a survival nomogram[J]. Biochem Biophys Res Commun, 2021, 585: 103-110. DOI: 10.1016/j.bbrc.2021.11.027. [25] TANG Z P, ZHAO P, ZHANG W X, et al. SALL4 activates PI3K/AKT signaling pathway through targeting PTEN, thus facilitating migration, invasion and proliferation of hepatocellular carcinoma cells[J]. Aging, 2022, 14(24): 10081-10092. DOI: 10.18632/aging.204446. [26] SUN J F, HU J Y, WANG G J, et al. RETRACTED ARTICLE: LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer[J]. J Exp Clin Cancer Res, 2018, 37(1): 1-11. DOI: 10.1186/s13046-018-0771-x. [27] PAWLOTSKY J M, NEGRO F, AGHEMO A, et al. EASL recommendations on treatment of hepatitis C: Final update of the series[J]. J Hepatol, 2020, 73(5): 1170-1218. DOI: 10.1016/j.jhep.2020.08.018. [28] DOS SANTOS W, DOS REIS M B, PORTO J, et al. Somatic targeted mutation profiling of colorectal cancer precursor lesions[J]. BMC Med Genom, 2022, 15(1): 143. DOI: 10.1186/s12920-022-01294-w. [29] FEDERICO A, RIENZO M, ABBONDANZA C, et al. Pan-cancer mutational and transcriptional analysis of the integrator complex[J]. Int J Mol Sci, 2017, 18(5): 936. DOI: 10.3390/ijms18050936. [30] FILLEUR S, HIRSCH J, WILLE A, et al. INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling[J]. Cancer Cell Int, 2009, 9(1): 1-9. DOI: 10.1186/1475-2867-9-28. [31] PFLEIDERER M M, GALEJ W P. Emerging insights into the function and structure of the Integrator complex[J]. Transcription, 2021, 12(5): 251-265. DOI: 10.1080/21541264.2022.2047583. [32] WILLIAMS L H, FROMM G, GOKEY N G, et al. Pausing of RNA polymerase Ⅱ regulates mammalian developmental potential through control of signaling networks[J]. Mol Cell, 2015, 58(2): 311-322. DOI: 10.1016/j.molcel.2015.02.003. [33] SABATH K, STÄUBLI M L, MARTI S, et al. INTS10-INTS13-INTS14 form a functional module of Integrator that binds nucleic acids and the cleavage module[J]. Nat Commun, 2020, 11: 3422. DOI: 10.1038/s41467-020-17232-2. ( |